Skip to main content

Table 2 Number of PET-positive lesions detected on 68 Ga-PSMA-617 and 18F-FDG PET/CT

From: A pilot study of 68 Ga-PSMA-617 PET/CT imaging and 177Lu-EB-PSMA-617 radioligand therapy in patients with adenoid cystic carcinoma

No.

Extrapulmonary metastases

Lung metastases

PSMA

FDG

PSMA

FDG

CT

Primary

Recurrent

Metastases

Primary

Recurrent

Metastases

1

1

1

2

1

1

3

1

1

4

1

4

0

3

5

1

21

1

18

6

1

1

15

22

26

7

1

1

9

13

19

8

1

10

1

8

10

10

10

9

1

9

0

7

7

4

7

10

1

36

1

33

4

2

4

11

1

0

12

12

15

20

13

30

30

12

18

25

14

0

9

11

15

20

20

10

14

16

16

7

19

22

17

4

11

17

18

10

17

21

19

9

19

24

20

16

16

16

21

14

16

21

22

11

13

13

23

10

11

11

24

9

20

20

25

0

3

3

26

16

14

27

12

19

22

28

0

6

6

29

8

11

11

30

13

13

13

Sum

157

141

202

301

358

P

0.016*

 < 0.001*

  1. *Difference is statistically significant